Home » Topics » Regulatory

Regulatory
RSS

Adderall XR program in adolescents to extend marketing exclusivity

May 13, 2003

FDA approves new flexible dosing regimen for Lantus

May 13, 2003

Cozaar approved for diabetics with kidney disease and high blood pressure in Canada

May 12, 2003

Once-monthly octreotide acetate improves visual acuity in cystoid macular edema

May 12, 2003

Santen files NDA for levofloxacin 1.5%

May 9, 2003

Effective use of transdermal buprenorphine in cancer and noncancer pain

May 9, 2003

Vioxx approved in Canada for use in rheumatoid arthritis

May 9, 2003

New Risperdal formulation launched

May 8, 2003

Extended-release ciprofloxacin in complicated urinary tract infections

May 8, 2003

Forest seeks label expansion for Lexapro to include panic disorder

May 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Aug. 19, 2025.
CSL to shave off 3,000 jobs, Seqirus vaccine unit
BioWorld
CSL Ltd.’s stock tumbled 16.88% on the news that it plans to cut 3,000 jobs and to hive off its Seqirus vaccine unit in a cost-cutting measure to save more than...
Skyhawk’s small-molecule RNA efforts draw Merck KGaA in $2B deal
BioWorld
Adding another name to an impressive roster of partners assembled over the past few years, Skyhawk Therapeutics Inc. inked a neurology-focused deal with Merck...
GI blow: Viking soldiers on with midstage oral obesity bid
BioWorld
Rates of adverse events (AEs) gave pause to some on Wall Street, and shares of Viking Therapeutics Inc. (NASDAQ:VKTX) fell 42%, or $17.73, to close Aug. 19 at...